tailieunhanh - Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model

Using killed microorganisms or their parts to stimulate immunity for cancer treatment dates back to the end of 19th century. Since then, it undergone considerable development. Our novel approach binds ligands to the tumor cell surface, which stimulates tumor phagocytosis. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN